INSM
Insmed Incorporated · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.0% ·
aandelenstroom +4.1% ·
netto nieuwe posities 0.0%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.33M | $149.97M | n/a | −2 |
| Q2 2026 | 156 | -6 | 147.06M | $15.68B | +6 | −13 |
| Q1 2026 | 166 | +6 | 152.11M | $24.63B | +9 | −4 |
| Q4 2025 | 159 | -1 | 156.45M | $27.23B | +1 | −1 |
| Q3 2025 | 21 | +1 | 121.03M | $17.43B | +1 | −1 |
| Q2 2025 | 18 | +1 | 70.35M | $7.08B | +2 | −1 |
| Q1 2025 | 14 | -1 | 33.99M | $2.59B | n/a | −1 |
| Q4 2024 | 15 | 0 | 31.46M | $2.17B | +1 | −1 |
| Q3 2024 | 14 | -1 | 23.46M | $1.71B | n/a | −1 |
| Q2 2024 | 15 | n/a | 25.91M | $1.74B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | JPMorgan Chase ✦ | 46.10M | n/a | $6.64B | 0.2% | n/c | 1 | SEC ↗ ×32 |
| 2 | The Vanguard Group ✦ (passief) | 19.94M | +13.0% | $2.87B | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passief) | 12.36M | +11.0% | $1.78B | 0.0% | ▲ Add | 2 | SEC ↗ ×18 |
| 4 | Fidelity (FMR) ✦ | 9.18M | +80.3% | $1.32B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 5 | T. Rowe Price ✦ | 6.93M | -38.3% | $998.20M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 5.66M | +65.3% | $814.73M | 0.7% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | State Street Global Advisors ✦ (passief) | 3.98M | -6.9% | $573.79M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 3.76M | +12.5% | $541.50M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Duquesne Family Office ✦ | 2.42M | +7.5% | $349.00M | 8.9% | ▲ Add | 6 | SEC ↗ |
| 10 | Millennium Management ✦ | 2.34M | +10.1% | $336.42M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 2.06M | +34.2% | $296.32M | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | Adage Capital Partners ✦ | 1.25M | -56.2% | $180.37M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 963.63K | n/a | $138.77M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 14 | Goldman Sachs Group ✦ | 829.32K | n/a | $119.43M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 15 | Two Sigma Investments ✦ | 772.78K | +105.2% | $111.29M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 16 | Wellington Management ✦ | 718.04K | -38.1% | $103.41M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 17 | Marshall Wace ✦ | 658.65K | -40.8% | $94.85M | 0.1% | ▼ Trim | 6 | SEC ↗ ×3 |
| 18 | Point72 Asset Management ✦ | 464.22K | -5.4% | $66.85M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 352.89K | +14.3% | $50.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 287.29K | +477.9% | $40.94M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 21 | Gotham Asset Management ✦ | 1.65K | Nieuw | $237,472 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Gotham Asset Management | $237,472 | 0.0% |
Verlaten
| Norges Bank | $194.73M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 664 houders, 192.22M aandelen, $30.07B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 25.00K aand · $3.10M
Director · 5.00K aand · $637,650
Officer · 239.85K aand · $31.96M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie